Table 1.

Demographics and Clinical Presentation.

	PSP (N = 11)	Healthy controls (N = 9)
Age (y)	68.4 ± 7.4	71.6 ± 6.6
Gender (m/f)	5/6	5/4
Education (y)	13.2 ± 3.2	12.9 ± 2.5
MMSE (median, range)	27, 25–29	28, 26–30
PSPRS (median, range)	30, 19–44	n/t
SEADL (median, range)	60, 50–90	n/t
Disease Duration (mo)	36 ± 19	n/a

Y, years; m, male; f, female; n/a, non applicable; n/t, non tested; MMSE, mini-mental state examination; PSPRS, progressive supranuclear palsy rating scale; SEADL, Schwab and England Activities of Daily Living scale; mo, months.